Did You Know...
...that Thomas Edison's patent application on his phonograph was approved by the Patent Office in just seven weeks? In contrast, it took Gordon Gould, the inventor of the laser, 30 years to obtain his patent -- finally awarded in 1988!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5258379 | Method of inhibiting gastric acid secretion with n-arylpiperazines The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.... | 11/02/1993 |
| 5158971 | Pharmaceutical compounds A pharmaceutical compound of the formula ##STR1## in which R1 is halo-C1-10 alkyl, C1-10 alkylthio, halo-C1-10 alkylthio or optionally substituted phenylthio, R2 is hydrogen or C1-4 al... | 10/27/1992 |
| 5158956 | Method of inhibiting gastric acid secretion with benzodioxanes The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.... | 10/27/1992 |
| 5135955 | Propanamine derivatives Substituted propanamines having anticoagulant or antifungal activity are disclosed. Also disclosed are methods of use involving the substituted propanamines as well as pharmaceutical compositions containing them.... | 08/04/1992 |
| 5130485 | N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents This invention relates to N-hydroxy-N-[3-(2-substituted phenyl)prop-2-enyl]ureas and thioureas, formulations containing those compounds, and methods of using such compounds as 5-lipoxygenase inhibiting agents.... | 07/14/1992 |
| 5096908 | Method of inhibiting gastric acid secretion The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.... | 03/17/1992 |
| 5063234 | Method of inhibiting demineralization of bone A method of inhibiting bone demineralization comprising administration of an effective amount of a compound having the formula ##STR1## where X is CH or N; Y is O or S; R1 is 2-propenyl, C1 -C3 alkyl, benzyl or substituted... | 11/05/1991 |
| 5028629 | 5-Lipoxygenase inhibitors This invention relates to 2-(substituted)-N-hydroxy-N-alkylcinnamamides of the formula: ##STR1## where R1 is C1 -C4 alkyl; n is 0 or 1; R2 is trifuloromethyl, C1 -C10 alkyl, phen(C1 | 07/02/1991 |
| 5011938 | 7-substituted bicyclic pyrazolidinones 7-Substituted bicyclic pyrazolidinone compounds as antimicrobials and the corresponding intermediates, are discussed or provided. The use of the antimicrobial compounds in pharmaceutical compositions and in methods for treating bacterial infections is set... | 04/30/1991 |
